In this podcast episode we will review the evidence demonstrating the variety of strategies capable of achieving partial reversal and regression of atherosclerosis in the human body, including aerobic exercise, the targeted lowering of atherogenic lipoproteins including LDL-C and Apolipoprotein-B (ApoB), the use of Icosapent Ethyl (Vascepa) in those with and without elevated triglycerides, blood pressure lowering agents including Angiotensin Receptor Blockers (ARBs), glucose-lowering agents such as Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, and medications with anti-inflammatory properties, including Colchicine. Additionally, we will review the preliminary data regarding atherosclerotic plaque regression and Glucagon-like Peptide 1 (GLP-1) Receptor Agonists.

References:

https://kevinforeymd.com/reverseASCVD/